@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ns1: <http://www.nanopub.org/nschema#> .
@prefix ns2: <https://example.org/levin-kg/> .
@prefix ns3: <https://w3id.org/levin-kg/> .
@prefix ns4: <http://purl.org/spar/cito/> .
@prefix prov: <http://www.w3.org/ns/prov#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<Nc0126d83a27548eebb46d20ded3b72ab#Head> {
    <Nc0126d83a27548eebb46d20ded3b72ab> a ns1:Nanopublication ;
        ns1:hasAssertion <Nc0126d83a27548eebb46d20ded3b72ab-assertion> ;
        ns1:hasProvenance <Nc0126d83a27548eebb46d20ded3b72ab-provenance> ;
        ns1:hasPublicationInfo <Nc0126d83a27548eebb46d20ded3b72ab-pubinfo> .
}

ns2:np-CHERNET2014-C1-10.18632_oncotarget.1935-assertion {
    ns2:claim-CHERNET2014-C1 a ns2:Assertion ;
        dcterms:description "Long-range hyperpolarization of distant somatic cells suppresses oncogene-induced tumorigenesis; native CLIC1-mediated chloride influx participates, and suppression requires HDAC1 (butyrate/transport model)." ;
        ns4:citesAsEvidence <https://doi.org/10.18632/oncotarget.1935> ;
        ns2:context "Xenopus laevis; KRAS^{G12D}, Gli1, Xrel3; Kv1.5 or high extracellular chloride; CLIC1 WT vs mutant; DN-HDAC1 and antibiotic manipulations; ITLS incidence." ;
        ns2:hasAssessment ns2:assessment-CHERNET2014-C1 ;
        ns3:hasEvidence ns2:evidence-CHERNET2014-C1-E1,
            ns2:evidence-CHERNET2014-C1-E2 .
}

ns2:np-CHERNET2016-C1-10.18632_oncotarget.8036-pubinfo {
    ns2:assessment-CHERNET2016-C1 a ns2:BayesianAssessment ;
        dcterms:description "Combined assuming independence across evidence items; exact/threshold p-values per figure legend." ;
        ns2:bayesFactorCombined 223.581811 ;
        ns2:calibrationMethod "Vovk–Sellke p-value calibration (Sellke, Bayarri & Berger, 2001)" ;
        ns2:weightOfEvidence_deciban 23.494365 .

    ns2:np-CHERNET2016-C1-10.18632_oncotarget.8036 dcterms:bibliographicCitation "Brook T. Chernet; Dany S. Adams; Maria Lobikin; Michael Levin (2016). Use of genetically encoded, light-gated ion translocators to control tumorigenesis. https://doi.org/10.18632/oncotarget.8036" ;
        dcterms:created "2025-10-01"^^xsd:date ;
        dcterms:creator ns2:generator ;
        dcterms:identifier "26988909" ;
        dcterms:source <https://doi.org/10.18632/oncotarget.8036> .

    ns2:generator a prov:SoftwareAgent ;
        dcterms:description "Constructs nanopublications with Bayesian weight-of-evidence estimates via Vovk–Sellke calibration." ;
        dcterms:license "CC0-1.0" ;
        dcterms:title "Levin-KG generator (wave Q)" .
}

ns2:np-CHERNET2016-C1-10.18632_oncotarget.8036-assertion {
    ns2:claim-CHERNET2016-C1 a ns2:Assertion ;
        dcterms:description "Optogenetic hyperpolarization (Arch or ChR2^{D156A}) significantly prevents KRAS^{G12D}-induced tumor-like structures (ITLS) and promotes regression (normalization) of existing tumors in vivo." ;
        ns4:citesAsEvidence <https://doi.org/10.18632/oncotarget.8036> ;
        ns2:context "Xenopus laevis tumor model; KRAS^{G12D}; Arch and ChR2^{D156A}; light stimulation regimens; incidence and normalization outcomes; qPCR marker normalization." ;
        ns2:hasAssessment ns2:assessment-CHERNET2016-C1 ;
        ns3:hasEvidence ns2:evidence-CHERNET2016-C1-E1,
            ns2:evidence-CHERNET2016-C1-E2 .
}

ns2:np-CHERNET2014-C1-10.18632_oncotarget.1935-provenance {
    ns2:np-CHERNET2014-C1-10.18632_oncotarget.1935-assertion prov:wasDerivedFrom <https://doi.org/10.18632/oncotarget.1935> .
}

<https://example.org/levin-kg/np-CHERNET2016-C1-10.18632_oncotarget.8036#Head> {
    ns2:np-CHERNET2016-C1-10.18632_oncotarget.8036 a ns1:Nanopublication ;
        ns1:hasAssertion ns2:np-CHERNET2016-C1-10.18632_oncotarget.8036-assertion ;
        ns1:hasProvenance ns2:np-CHERNET2016-C1-10.18632_oncotarget.8036-provenance ;
        ns1:hasPublicationInfo ns2:np-CHERNET2016-C1-10.18632_oncotarget.8036-pubinfo .
}

ns2:np-CHERNET2014-C1-10.18632_oncotarget.1935-pubinfo {
    ns2:np-CHERNET2014-C1-10.18632_oncotarget.1935 dcterms:bibliographicCitation "Brook T. Chernet; Michael Levin (2014). Transmembrane voltage potential of somatic cells controls oncogene-mediated tumorigenesis at long-range. https://doi.org/10.18632/oncotarget.1935" ;
        dcterms:created "2025-10-01"^^xsd:date ;
        dcterms:creator ns2:generator ;
        dcterms:identifier "24830454" ;
        dcterms:source <https://doi.org/10.18632/oncotarget.1935> .

    ns2:assessment-CHERNET2014-C1 a ns2:BayesianAssessment ;
        dcterms:description "Combined assuming independence across evidence items; exact/threshold p-values per figure legend." ;
        ns2:bayesFactorCombined 19.619699 ;
        ns2:calibrationMethod "Vovk–Sellke p-value calibration (Sellke, Bayarri & Berger, 2001)" ;
        ns2:weightOfEvidence_deciban 12.926923 .

    ns2:generator a prov:SoftwareAgent ;
        dcterms:description "Constructs nanopublications with Bayesian weight-of-evidence estimates via Vovk–Sellke calibration." ;
        dcterms:license "CC0-1.0" ;
        dcterms:title "Levin-KG generator (wave Q)" .
}

<https://example.org/levin-kg/np-CHERNET2014-C1-10.18632_oncotarget.1935#Head> {
    ns2:np-CHERNET2014-C1-10.18632_oncotarget.1935 a ns1:Nanopublication ;
        ns1:hasAssertion ns2:np-CHERNET2014-C1-10.18632_oncotarget.1935-assertion ;
        ns1:hasProvenance ns2:np-CHERNET2014-C1-10.18632_oncotarget.1935-provenance ;
        ns1:hasPublicationInfo ns2:np-CHERNET2014-C1-10.18632_oncotarget.1935-pubinfo .
}

ns2:np-CHERNET2016-C1-10.18632_oncotarget.8036-provenance {
    ns2:np-CHERNET2016-C1-10.18632_oncotarget.8036-assertion prov:wasDerivedFrom <https://doi.org/10.18632/oncotarget.8036> .
}

